Nanophthalmic uveal effusion syndrome after prophylactic laser treatment

G. Lesnoni, T. Rossi, A. Nistri, B. Boccassini

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose. We report a case of nanophthalmic uveal effusion syndrome (NUES) with total exudative retinal detachment (RD) after prophylactic argon laser (AL) treatment. The RD subsided and eventually resolved with i.v. steroid therapy. Methods. A 45-year-old woman was referred to us with NUES and total exudative RD after prophylactic AL treatment for retinoschisis performed elsewhere. The patient had been scheduled for surgical intervention and was given i.v. prednisolone. Results. Two days after starting i.v. prednisolone, the subretinal fluid partially resolved. Intervention had therefore been postponed. After 15 days the RD almost disappeared and vision improved to 20/400. Ten days later the macula was fiat and vision was 20/200. At the six-month follow-up visit vision was 20/40. Conclusions. To our knowledge this is the first report of NUES and total exudative RD following AL treatment that resolved with i.v. steroid therapy alone. Since the AL treatment clearly seemed to play a role in the pathogenesis of the NUES and associated RD we strongly advise careful assessment of the risk/benefit ratio of prophylactic laser treatment in nanophthalmic patients. Although sclerectomy and vortex vein decompression are well-established techniques, we believe steroid therapy might be tried before proceeding to surgery.

Original languageEnglish
Pages (from-to)315-318
Number of pages4
JournalEuropean Journal of Ophthalmology
Volume9
Issue number4
Publication statusPublished - Oct 1999

Fingerprint

Lasers
Retinal Detachment
Argon
Steroids
Therapeutics
Prednisolone
Retinoschisis
Subretinal Fluid
Decompression
Veins
Odds Ratio

Keywords

  • Laser treatment
  • Nanophthalmos
  • Retinoschisis
  • Steroid therapy
  • Uveal effusion

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Lesnoni, G., Rossi, T., Nistri, A., & Boccassini, B. (1999). Nanophthalmic uveal effusion syndrome after prophylactic laser treatment. European Journal of Ophthalmology, 9(4), 315-318.

Nanophthalmic uveal effusion syndrome after prophylactic laser treatment. / Lesnoni, G.; Rossi, T.; Nistri, A.; Boccassini, B.

In: European Journal of Ophthalmology, Vol. 9, No. 4, 10.1999, p. 315-318.

Research output: Contribution to journalArticle

Lesnoni, G, Rossi, T, Nistri, A & Boccassini, B 1999, 'Nanophthalmic uveal effusion syndrome after prophylactic laser treatment', European Journal of Ophthalmology, vol. 9, no. 4, pp. 315-318.
Lesnoni G, Rossi T, Nistri A, Boccassini B. Nanophthalmic uveal effusion syndrome after prophylactic laser treatment. European Journal of Ophthalmology. 1999 Oct;9(4):315-318.
Lesnoni, G. ; Rossi, T. ; Nistri, A. ; Boccassini, B. / Nanophthalmic uveal effusion syndrome after prophylactic laser treatment. In: European Journal of Ophthalmology. 1999 ; Vol. 9, No. 4. pp. 315-318.
@article{fb61e1b64d1a4897a31eed3a0b0c1fbe,
title = "Nanophthalmic uveal effusion syndrome after prophylactic laser treatment",
abstract = "Purpose. We report a case of nanophthalmic uveal effusion syndrome (NUES) with total exudative retinal detachment (RD) after prophylactic argon laser (AL) treatment. The RD subsided and eventually resolved with i.v. steroid therapy. Methods. A 45-year-old woman was referred to us with NUES and total exudative RD after prophylactic AL treatment for retinoschisis performed elsewhere. The patient had been scheduled for surgical intervention and was given i.v. prednisolone. Results. Two days after starting i.v. prednisolone, the subretinal fluid partially resolved. Intervention had therefore been postponed. After 15 days the RD almost disappeared and vision improved to 20/400. Ten days later the macula was fiat and vision was 20/200. At the six-month follow-up visit vision was 20/40. Conclusions. To our knowledge this is the first report of NUES and total exudative RD following AL treatment that resolved with i.v. steroid therapy alone. Since the AL treatment clearly seemed to play a role in the pathogenesis of the NUES and associated RD we strongly advise careful assessment of the risk/benefit ratio of prophylactic laser treatment in nanophthalmic patients. Although sclerectomy and vortex vein decompression are well-established techniques, we believe steroid therapy might be tried before proceeding to surgery.",
keywords = "Laser treatment, Nanophthalmos, Retinoschisis, Steroid therapy, Uveal effusion",
author = "G. Lesnoni and T. Rossi and A. Nistri and B. Boccassini",
year = "1999",
month = "10",
language = "English",
volume = "9",
pages = "315--318",
journal = "European Journal of Ophthalmology",
issn = "1120-6721",
publisher = "Wichtig Publishing",
number = "4",

}

TY - JOUR

T1 - Nanophthalmic uveal effusion syndrome after prophylactic laser treatment

AU - Lesnoni, G.

AU - Rossi, T.

AU - Nistri, A.

AU - Boccassini, B.

PY - 1999/10

Y1 - 1999/10

N2 - Purpose. We report a case of nanophthalmic uveal effusion syndrome (NUES) with total exudative retinal detachment (RD) after prophylactic argon laser (AL) treatment. The RD subsided and eventually resolved with i.v. steroid therapy. Methods. A 45-year-old woman was referred to us with NUES and total exudative RD after prophylactic AL treatment for retinoschisis performed elsewhere. The patient had been scheduled for surgical intervention and was given i.v. prednisolone. Results. Two days after starting i.v. prednisolone, the subretinal fluid partially resolved. Intervention had therefore been postponed. After 15 days the RD almost disappeared and vision improved to 20/400. Ten days later the macula was fiat and vision was 20/200. At the six-month follow-up visit vision was 20/40. Conclusions. To our knowledge this is the first report of NUES and total exudative RD following AL treatment that resolved with i.v. steroid therapy alone. Since the AL treatment clearly seemed to play a role in the pathogenesis of the NUES and associated RD we strongly advise careful assessment of the risk/benefit ratio of prophylactic laser treatment in nanophthalmic patients. Although sclerectomy and vortex vein decompression are well-established techniques, we believe steroid therapy might be tried before proceeding to surgery.

AB - Purpose. We report a case of nanophthalmic uveal effusion syndrome (NUES) with total exudative retinal detachment (RD) after prophylactic argon laser (AL) treatment. The RD subsided and eventually resolved with i.v. steroid therapy. Methods. A 45-year-old woman was referred to us with NUES and total exudative RD after prophylactic AL treatment for retinoschisis performed elsewhere. The patient had been scheduled for surgical intervention and was given i.v. prednisolone. Results. Two days after starting i.v. prednisolone, the subretinal fluid partially resolved. Intervention had therefore been postponed. After 15 days the RD almost disappeared and vision improved to 20/400. Ten days later the macula was fiat and vision was 20/200. At the six-month follow-up visit vision was 20/40. Conclusions. To our knowledge this is the first report of NUES and total exudative RD following AL treatment that resolved with i.v. steroid therapy alone. Since the AL treatment clearly seemed to play a role in the pathogenesis of the NUES and associated RD we strongly advise careful assessment of the risk/benefit ratio of prophylactic laser treatment in nanophthalmic patients. Although sclerectomy and vortex vein decompression are well-established techniques, we believe steroid therapy might be tried before proceeding to surgery.

KW - Laser treatment

KW - Nanophthalmos

KW - Retinoschisis

KW - Steroid therapy

KW - Uveal effusion

UR - http://www.scopus.com/inward/record.url?scp=0033369873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033369873&partnerID=8YFLogxK

M3 - Article

C2 - 10651198

AN - SCOPUS:0033369873

VL - 9

SP - 315

EP - 318

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 4

ER -